Tissue
diagnosis is important tool in diagnosis, monitoring, and management
of different types of cancer conditions. Recognition of sign and
symptoms of disease are done through biopsy, a process of taking
sample from region of interest such as skin, tissue or tumor for
further diagnosis. Biopsy are primarily done to look for cancer
detection or to detect rejection of transplanted organ draft.
Biopsy
is done to identify likely cause of cancerous and non-cancerous
tissue, which are unable to detect through CT-scan or X-rays.
Depending on area of sample collection various biopsy procedures are
done such as endoscopic biopsy, bone marrow biopsy, skin biopsy,
kidney biopsy, liver biopsy, and prostate biopsy. Furthermore biopsy
can be done using needle biopsy, CT guided biopsy, Ultrasound biopsy,
and surgical biopsy for the tissue diagnostic. According to the
American journal of Nephrology, 2015, Australia has the highest
numbers of annual renal biopsy rates (215 persons/million
person/year) followed by the Finland (176 persons/million
person/year) and U.S. (175 persons/million person/year). The
increased numbers of biopsy procedure likely to fuel the growth of
tissue diagnostic market, in near future.
Get
Exclusive Sample Copy of Tissue Diagnostic Research @
https://www.coherentmarketinsights.com/insight/request-sample/1112
Rising
prevalence of different cancer incidences is major driving factor
boosting the tissue diagnostic market. According to American cancer
Society (ACS), 1.6 million new cases of cancer diagnosed in the U.S.,
in 2016. In addition, increase research funding in cancer treatment
and growing healthcare expenditure likely to show gradual rise in
tissue diagnostic market. National Cancer Institute, in 2015, spends
US$ 4,480 million on various types of cancer research which includes
breast cancer, colorectal cancer, cervical cancer, liver cancer, lung
cancer, leukemia, ovarian cancer and uterine cancer.
Rise
in the prevalence of cancer incidences to boost the tissue diagnostic
market
According
to the United States Cancer statistics report published in 2014 by
Centers of Disease Control and Prevention (CDC), between 1999 and
2014, more than 1600 people a day, died due to the cause of cancer.
Although screening tests helps to detect cancer condition at early
stage, data from Healthy People 2020, an initiative form Department
of Health and Human Services, reveals that screening rate is still
below the national targets set. Combined data collected from CDC and
National cancer institute (NCI) focus on the top 3 cancer incidences
in male and female. In male prostate cancer incidence are higher,
while in females breast cancer are most dominated, followed by lung
and colon cancer respectively in both male and female.
New
and advanced methods of tissue diagnosis favors the market growth
Innovation
in tissue diagnostic process for the efficient diagnostic testing
such as Fluorescence in situ hybridization (FISH),
Immunohistochemistry (IHC) and In situ hybridization (ISH) raises the
opportunity to grow tissue diagnostic market in future. In September
2017, researchers at the University of Texas, developed a new way of
diagnosis by creating pen named as “MasSpec Pen”, which is
handheld devices able to distinguish healthy tissue and tumor tissue
in just 10 seconds, more than 150 times quicker than existing
technology. These new tool provides improvement in cancer treatment
and minimizes the chances of recurrence by offering precise
diagnostic information, which eventually favors the growth in tissue
diagnostic market.
Global
Eminent Players
Key
players operated in the tissue diagnostic market are Biocare Medical,
Agilent technologies, Thermo Fisher Scientific, Sigma-Aldrich, Roche
Diagnostics, Danaher corp., Biogenex Laboratories, Life Technologies
and Abbott laboratories.
Tissue
diagnostic market taxonomy:
By
Technology:
-
In situ hybridization
-
Digital pathology
-
Immunohistochemistry
-
Tissue microarray
-
Special staining
By
Disease:
-
Breast cancer
-
Lymphoma cancer
-
Gastric cancer
-
Prostate cancer
Browse
In-Depth Analysis Research Report @
https://www.coherentmarketinsights.com/ongoing-insight/tissue-diagnostic-market-1112
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment